Inhibition of Lung Microbiota-Derived Proapoptotic Peptides Ameliorates Acute Exacerbation of Pulmonary Fibrosis

Researchers demonstrated that an anticorisin monoclonal antibody ameliorated lung fibrosis by significantly inhibiting acute exacerbation in the human transforming growth factorβ1 model and acute lung injury in the bleomycin model.